Public Health Meaningful Use:
All external hyperlinks are provided for your information and for the benefit of the
general public. The Department of Health Services does not testify to, sponsor, or endorse the accuracy of the information provided on externally linked pages.
Wisconsin's Division of Public Health (DPH) has the technical capacity to
accept syndromic surveillance data
from hospitals and Eligible Professionals. Providers presently have two
options for submitting syndromic surveillance data. One option is for the
provider to subscribe to the
Wisconsin Statewide Health Information Network
(WISHIN) services and electronically test and send syndromic surveillance data to
public health via WISHIN using a secure VPN HL7 interface. WISHIN sends the data
to Wisconsin's secure space in
BioSense 2.0, a secure,
nationwide public health tracking tool. The second option is for the provider
to send syndromic surveillance data directly to Wisconsin's secure space in BioSense 2.0.
Regardless of which transmission path is used, any provider that wants to satisfy the
Meaningful Use objective for syndromic surveillance data submission has to meet the HL7 2.5.1 standards and
conform to the HL7 implementation specifications found in the
Information Network (PHIN) message guides for syndromic surveillance. Also, the technology used
to generate the ADT HL7 messages has to be a
federally certified 2014 Edition EHR
technology for the syndromic surveillance meaningful use objective.
DPH has limited resource capacity to test with and onboard new providers.
DPH is prioritizing syndromic surveillance testing and onboarding for the
following categories of providers:
- Hospitals (either part of an Integrated Delivery Network or independent)
- Clinics in Integrated Delivery Networks that include hospitals
- Clients of a Health Information Exchange
It is unlikely testing will begin in 2014 for other categories of providers. Providers in Stage 2
of Meaningful Use can meet the syndromic surveillance objective even if they do not begin testing
during their EHR reporting period as long as they register with DPH no later than 60 days after the
start of their reporting period, are responsive to DPH communications, and have a federally certified
2014 Edition EHR technology certified for syndromic surveillance data submission. DPH requires all providers,
whether participating in Meaningful Use (any stage) or not, to register if they want to test and onboard for
electronic submission of syndromic surveillance data to public health. Providers in Stage 1 of Meaningful Use that
remain in the registration queue because of a public health agency's or its third-party agent's lack of capacity
to test would be eligible to take an exclusion for the syndromic surveillance objective.
To register with the syndromic surveillance program, please visit the
PHREDS registration page. To register, you will need the
- Organization name
- Primary technical contact information (phone number and email address)
- Primary Meaningful Use contact information, if applicable (phone number and email address)
- Primary address
- Meaningful Use stage and year, if applicable
- EHR vendor name
- EHR product name and version
- Submission option (WISHIN or direct to BioSense 2.0)
For providers onboarding to meet Meaningful Use, the sydromic surveillance and other program areas will not
begin the onboarding process until you register.
syndromic surveillance onboarding checklist (PDF, 100 KB)
to learn how to submit data electronically.
If you have questions concerning the registration process, please email
If you have questions concerning the technical onboarding process for syndromic surveillance, please email
the Syndromic Surveillance Program at
Return to Public Health Meaningful Use home page
Last Revised: May 02, 2014